Re:Insulin is way too expensive. California has a solution: ...
by RcouF1uZ4gsC on Thursday February 09, 2023 @02:59PM
(#34730416)
>. For a generic insulin to get FDA approval it needs bioequivalence which is a lot like running the original safety and effect studies over again
That is incorrect. A bioequivalence study is much simpler and cheaper than the original safety and efficacy studies.
You do not need to prove that safety and efficacy of the drug, only that you are delivering the equivalent of the originally studied drug at the same doses.
That is incorrect. A bioequivalence study is much simpler and cheaper than the original safety and efficacy studies.
You do not need to prove that safety and efficacy of the drug, only that you are delivering the equivalent of the originally studied drug at the same doses.
https://en.wikipedia.org/wiki/Bioequivalence